Skip to main content
. 2017 May 19;8(5):146. doi: 10.3390/genes8050146

Figure 3.

Figure 3

Ultrasensitive residual C-peptide concentrations (pmol/L) compared between patients with the highest-risk haplotype combination and other moderate-risk and low-risk haplotypes, samples taken on average 14.3 ± 2.3 or 13.2 ± 2.6 years after diabetes onset.